Innate Pharma (IPHA) Establishes New At-The-Market Program on Nasdaq

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/25/2026

1. RNG
2. DECK
3. WDC
4. BMY
5. BYD
6. SPOT
7. WCN
8. TSCO
9. BE
10. IVBIY

Go back to Innate Pharma (IPHA) Establishes New At-The-Market Program on Nasdaq

Innate Pharma Establishes a New At-The-Market (“ATM”) Program on Nasdaq

April 26, 2023 4:50 PM EDT

MARSEILLE, France--(BUSINESS WIRE)-- Regulatory News:

Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (Innate or the Company) today announced that it has filed a prospectus supplement with the Securities and Exchange Commission (SEC) relating to a new At-The-Market (ATM) program. Pursuant to this program, the Company may offer and sell to eligible investors (as described below) a total gross amount of up to $75 million of American Depositary Shares (ADS), each ADS representing one ordinary share of Innate, from time to time in sales deemed to be an at the market offering... More